12
Participants
Start Date
June 30, 2006
Primary Completion Date
May 31, 2009
Study Completion Date
April 30, 2012
carboplatin
AUC=2 intravenously on days 1, 8 and 15. Re-treat every 4 weeks until progression, unacceptable toxicity, or refusal
paclitaxel
100mg/m\^2 intravenously on days 1, 8 and 15. Re-treat every 4 weeks until progression, unacceptable toxicity, or refusal
temozolomide
150mg/m\^2 at cycle 1, 200mg/m\^2 at cycle 2 and beyond, orally on days 1-5. Re-treat every 4 weeks until progression, unacceptable toxicity, or refusal. One treatment cycle=four weeks
Mayo Clinic Cancer Center, Rochester
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER